ERBB3 and pancreatic neoplasm: Friess et al have reported that HER3 mRNA was 6.7 fold elevated in pancreatic cancer as compared to normal pancreas, which was further confirmed by Immunohistochemistry showing that 47% (27/58) of pancreatic cancer tissues expressed HER3 [16].